Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized Rib Fractures
1 other identifier
observational
1,064
1 country
1
Brief Summary
The study aims to investigate the effect of surgical stabilisation of rib fractures (SSRF) on clinical outcomes measured during the hospital stay (mortality, days on a mechanical ventilator, intensive care unit and hospital length of stay, rate of complications). Furthermore, the effect of the patients age and overall injury severity on the outcomes after SSRF will be investigated. We hypothesise that the combination of high age and high injury severity will lead to worse outcomes after SSRF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 31, 2024
CompletedFirst Posted
Study publicly available on registry
June 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 29, 2026
April 1, 2026
1.7 years
May 31, 2024
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
In hospital-mortality
Mortality rate from injury to initial hospital discharge, binary
From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.
Intensive care unit length of stay
The duration in days a patient spent in the intensive care unit from the time of hospital admission to the time of initial hospital discharge.
From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.
Secondary Outcomes (7)
Intubation rate
From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.
Multi-organ failure
From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.
Single organ failure
From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.
Sepsis
From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.
Lung-failure
From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.
- +2 more secondary outcomes
Study Arms (2)
Operative
Patients receiving surgical stabilisation of rib fractures (SSRF) by any operative technique
Non-operative
Patients not receiving surgical stabilisation of rib fractures (SSRF)
Interventions
Surgical stabilisation of rib fractures using any fixation technique (including but not limited to plate fixation, intramedullary fixation, wire fixation) via any operative approach (including but not limited to open external approach, minimally invasive approach, thoracoscopic approach, thoracotomy approach).
Any supportive or specific treatment of rib fractures excluding surgical stabilisation of rib fractures. This includes, but is not limited to analgesia, physiotherapy, non-invasive ventilation, mechanical ventilation, oxygen-supplementation
Eligibility Criteria
The Patients will be sampled from all patients treated in the department for trauma, hand and reconstructive surgery of the university hospital Muenster
You may qualify if:
- Patients of the University Hospital Muenster
- Coded serial rib fractures (ICD S22.4 and S22.5)
- Treatment for the rib fractures between 2019 and 2023
You may not qualify if:
- pathological rib fractures (due to suspected malignancy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department for trauma, hand and reconstructive surgery, University hospital Muenster
Münster, North Rhine-Westphalia, 48149, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Steffen Rosslenbroich, PD Dr. med.
Department for trauma, hand and reconstructive surgery, University hospital Muenster
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2024
First Posted
June 18, 2024
Study Start
May 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
April 29, 2026
Record last verified: 2026-04